Sharon Johnson, Executive Vice President for Delivery Management
Vectura Group announced Sharon Johnson has been appointed to the position of Executive Vice President for Delivery Management, a newly-created leadership role. In her new position, Johnson will build an end-to-end approach to ensuring successful customer acquisition and program management, as well as managing the regulatory affairs and medical affairs departments. She joins the Group on February 10, 2020.
“Sharon has built an enviable reputation as an exceptional leader in the pharmaceutical services space and has a strong track record of transformational leadership, talent development and execution excellence,” Will Downie, CEO of Vectura, said. “Our new structure will support growth and sharpen our focus on working with our clients to bring more inhalation medicines to market.”
“Having spent my entire career in the healthcare arena, it is a true privilege to join Vectura, a company with such a rich scientific heritage in the inhalation space. I look forward to working with my colleagues on the executive leadership team and wider business to help combine deep science and agile processes that will accelerate the development of new and exciting inhaled medicines for patients,” Johnson said.
Johnson has more than thirty years of experience in the pharmaceutical industry, and prior to joining Vectura has held a number of executive positions, most recently as Senior Vice President, Global Quality and Regulatory Affairs at Catalent. Earlier in her career, she held the position of Vice President of Quality for GE Healthcare’s Medical Diagnostic Division, and worked in roles of increasing responsibility for Baxter Healthcare and Sanofi Aventis.
Johnson holds a postgraduate Diploma in Industrial Pharmaceutical Studies with Distinction from Brighton University and a BS Honors degree in Biological Sciences/Microbiology from North East Surrey College of Technology.